Santen Pharmaceutical Co., Ltd. Share Price Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Börse Stuttgart
20:56:14 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.10 EUR | -1.94% |
|
+2.02% | +16.09% |
| 08-06 | Santen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-27 | Glaukos' Trial of Preserflo MicroShunt Completes Enrollment | MT |
| Market Cap | 588B 3.77B 3.24B 3.05B 2.78B 5.21B 356B 5.22B 36.02B 13.98B 182B 14.14B 13.83B | P/E 2027 * |
15.2x | P/E 2028 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 541B 3.47B 2.98B 2.81B 2.56B 4.8B 327B 4.81B 33.16B 12.87B 168B 13.01B 12.73B | EV / Sales 2027 * |
1.78x | EV / Sales 2028 * | 1.63x |
| Free-Float |
96.71% | Yield 2027 * |
2.28% | Yield 2028 * | 2.56% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4536 | Delayed | |
OTC Markets
| SNPH.F | Delayed | |
|
Deutsche Boerse AG
| SZD | Delayed | |
|
Börse Stuttgart
| SZD | Delayed | |
|
Boerse Muenchen
| SZD | Real-time | |
|
Tradegate
| SZD | Real-time |
| 29/09/23 | ETF der Woche: Back to the Roots | |
| 28/09/23 | ETF van de week: terug naar de basis | |
| 28/09/23 | L'ETF della settimana: ritorno ai fondamentali | |
| 28/09/23 | ETF de la semaine : Retour aux fondamentaux | |
| 15/02/21 | Nicox S A : A suivre aujourd'hui |
| 1 week | +4.04% | ||
| Current month | +3.52% | ||
| 1 month | +1.98% | ||
| 3 months | +3.52% | ||
| 6 months | +15.73% | ||
| Current year | +18.39% |
| 1 week | 9.75 |  | 10.3 |
| 1 month | 9.75 | | 10.8 |
| 3 years | 7.8 | | 12 |
| 5 years | 6.4 | | 13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 67 | 31/08/2022 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Daisuke Nakata
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
BRD | Director/Board Member | 67 | 22/06/2017 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 31/05/2024 |
Rie Nakajima
BRD | Director/Board Member | 48 | 31/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.94% | +2.02% | +13.19% | +21.89% | 3.86B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,034B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 671B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 188B | |
| Average | -0.99% | +1.10% | +26.79% | +48.21% | 412.97B | |
| Weighted average by Cap. | -1.10% | +0.51% | +36.59% | +66.16% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304B 1.95B 1.67B 1.58B 1.44B 2.69B 184B 2.7B 18.62B 7.22B 94.26B 7.31B 7.15B | 314B 2.01B 1.73B 1.63B 1.49B 2.78B 190B 2.79B 19.24B 7.47B 97.43B 7.55B 7.39B |
| Net income | 38.19B 245M 211M 198M 181M 339M 23.1B 339M 2.34B 908M 11.85B 919M 899M | 41.4B 265M 228M 215M 196M 367M 25.05B 368M 2.54B 985M 12.85B 996M 974M |
| Net Debt | -46.74B -300M -258M -242M -222M -414M -28.28B -416M -2.87B -1.11B -14.51B -1.12B -1.1B | -75.89B -486M -418M -394M -360M -673M -45.91B -675M -4.65B -1.81B -23.56B -1.83B -1.79B |
| Date | Price | Change |
|---|---|---|
| 04/09/26 | €10.10 | -1.94% |
| 03/09/26 | €10.30 | +1.98% |
| 02/09/26 | €10.10 | +1.51% |
| 01/09/26 | €9.950 | 0.00% |
| 31/08/26 | €9.950 | +2.05% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
